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We investigated whether cortical glutamatergic and GABAergic releasemachineries can be
differentiated on the basis of the nature and amount of proteins they express, by perform-
ing a quantitative analysis of the degree of co-localization of synaptotagmin (SYT) 1 and
2, synaptic vesicle protein 2 (SV2) A and B, and Rab3a and c in VGLUT1+, VGLUT2+, and
VGAT+ terminals and synaptic vesicles (SVs) in rat cerebral cortex. Co-localization studies
showed that VGLUT1 puncta had high levels of SV2A and B and of Rab3c, intermediate
levels of SYT1, and low levels of SYT2 and Rab3c; VGLUT2 puncta exhibited intermedi-
ate levels of all presynaptic proteins studied; whereas vesicular GABA transporter (VGAT)
puncta had high levels of SV2A and SYT2, intermediate levels of SYT1, Rab3a, and Rab3c,
and low levels of SV2B. Since SV2B is reportedly expressed by glutamatergic neurons and
we observed SV2B expression in VGAT puncta, we performed electron microscopic stud-
ies and found SV2B positive axon terminals forming symmetric synapses. Immunoisolation
studies showed that the expression levels of the protein isoforms varied in the three pop-
ulations of SVs. Expression of SYT1 was highest in VGLUT1–SVs, while SYT2 expression
was similar in the three SV groups. Expression of SV2A was similarly high in all three SV
populations, except for SV2B levels that were very low in VGAT SVs. Finally, Rab3a levels
were similar in the three SV groups, while Rab3c levels were highest inVGLUT1–SVs.These
quantitative results extend our previous studies on the differential expression of presynap-
tic proteins involved in neurotransmitter release in GABAergic and glutamatergic terminals
and indicate that heterogeneity of the respective release machineries can be generated
by the differential complement of SV proteins involved in distinct stages of the release
process.
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INTRODUCTION
The possibility that glutamatergic and GABAergic release
machineries can be differentiated on the basis of the proteins they
express has attracted considerable interest (e.g., Sugino et al., 2006;
Micheva et al., 2010). In previous studies, we have approached
this question by investigating quantitatively the localization of
synapsin I and II (SYNI and II), synaptophysin I and II (SYPI and
II), synaptosomal-associated protein (SNAP)-25 and SNAP-23,
synaptogyrin (SGYR) 1 and 3, synaptobrevin/vesicle-associated
membrane protein (VAMP) 1 and 2, and syntaxin 1A and 1B
(STX1A and B) in vesicular GABA transporter (VGAT)-positive
(+) GABAergic and vesicular glutamate transporter VGLUT1+
andVGLUT2+ glutamatergic axon terminals (AT) in cerebral cor-
tex (Bragina et al., 2007,2010). The results show that the expression
of these presynaptic proteins in neocortex varies both between glu-
tamatergic and GABAergic terminals and betweenVGLUT1+ and
VGLUT2+ glutamatergic terminals (Bragina et al., 2007, 2010).
To further deﬁne the complement of proteins participating in
transmitter release in GABAergic and glutamatergic terminals, we
performed a quantitative analysis of the localization of synapto-
tagmin (SYT) 1 and 2, synaptic vesicle protein 2 (SV2) A and B,
and Rab3a and c in VGLUT1+, VGLUT2+, and VGAT+ termi-
nals and synaptic vesicles (SVs) of the cerebral cortex of adult
rats. SYT1 and 2 are the main SYT isoforms present in SVs (Sud-
hof, 2002; Xu et al., 2007). They are known Ca2+ sensors for fast
synchronous release and exhibit distinct expression patterns and
properties (Geppert et al., 1994b; Fernandez-Chacon et al., 2001;
Pang et al., 2006a,b; Xu et al., 2007), and SYT2 appears to be associ-
ated to inhibitory neurons and to operate at fast signaling synapses
(Geppert et al., 1994b; Pang et al., 2006a,b; Sun et al., 2007). SV2
is a component of all vertebrate SVs (Buckley and Kelly, 1985);
it plays a crucial role in the trafﬁcking of SYT to SVs and regu-
lates the effectiveness of calcium in inducing vesicle fusion. SV2A
is expressed ubiquitously in the brain, whereas SV2B expression
is restricted to forebrain and seems to be lacking in GABAergic
neurons (Bajjalieh et al., 1993, 1994; Gronborg et al., 2010). Small
GTPases of the Rab family are thought to confer membrane speci-
ﬁcity in intracellular fusion reactions (Zerial and McBride, 2001;
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Pfeffer andAivazian, 2004), and to control release probability,with
implications for synaptic plasticity (Schluter et al., 2004, 2006).
Rab3a is the most robustly expressed Rab protein in the brain
(Geppert et al., 1994a), and an abundant SVs protein (Fischer von
Mollard et al., 1990); Rab3c has also been localized to SVs in most
brain areas, although at variable levels (Schluter et al., 2002).
Here we report that in the cerebral cortex of adult rats SYT2,
SV2B, and Rab3c exhibit signiﬁcant differences both in the distrib-
ution and expression levels between glutamatergic and GABAergic
AT and SVs, and that some GABAergic AT express SV2B.
MATERIALS AND METHODS
ANIMALS AND TISSUE PREPARATION
Adult male Sprague-Dawley rats (190–220 g; Charles River, Milan,
Italy) were used. All studies were performed in accordance with
the E.C. Council Directive 86/609 (November 24, 1986) and were
approved by the local authority veterinary service. Animals were
kept under a dark–light cycle of 12 h and permitted food and water
ad libitum.
For Western blotting, rats were anesthetized with chloral
hydrate (300 mg/kg i.p.) and decapitated.Homogenization of neo-
cortex, membrane preparation, protein determination, and SDS-
PAGE analysis and immunoblotting were performed as described
(Bragina et al., 2006). Precast gels (Tris–HCl; BioRad, Hercules,
CA, USA) were used at 15% polyacrylamide concentration for
Rab3 isoforms and at 7.5% for the remaining proteins. For
immunocytochemistry, ratswere anesthetizedwith chloral hydrate
(300 mg/kg i.p.), and perfused through the ascending aorta with
saline followed by 4% paraformaldehyde in 0.1 M phosphate
buffer (PB; pH 7.4). Brains were postﬁxed for 2 h (immunoﬂuo-
rescence) or 24 h (electron microscopy) at 4˚C in the same ﬁxative,
cut with a Vibratome into 50μm thick sections, and processed.
ANTIBODIES
Primary antibodies used in these studies are listed in Table 1.
Western blots were performed to verify antibodies speciﬁcity;
nitrocellulose ﬁlters were probed with antibodies to VGLUT1,
VGLUT2, VGAT, SYT1 and 2, SV2A and B, and Rab3a and c at
the dilutions reported in Table 1. After exposure to the appropriate
peroxidase-conjugated antibodies (Vector; Burlingame,CA,USA),
immunoreactive bands were visualized by BioRad Chemidoc and
Quantity One software (BioRad, Hemel Hempstead, UK) using
the SuperSignal West Pico (Rockford, IL, USA) chemiluminescent
substrate. In cortical crudemembrane fractions, all antibodies rec-
ognized bands of predicted molecular mass (Figure 1; Matteoli
et al., 1991; Bajjalieh et al., 1993; Ullrich et al., 1994; Belloc-
chio et al., 1998; Chaudhry et al., 1998; Schluter et al., 2002;
Varoqui et al., 2002).
CO-LOCALIZATION STUDIES
Vibratome sections from rat brains were incubated for 1 h in
normal goat serum (NGS; 10% in PB), and overnight at room
Table 1 | Primary antibodies.
Antibodies Host˚ Dilution* Source Characterization
VGAT Rabbit 1:500 (IF) Synaptic system/131003 Takamori et al. (2000)
1:1000 (WB)
1:500 (II)
VGAT Mouse 1:50 (IF) Synaptic system/131011 Bogen et al. (2006), Tafoya et al. (2006)
1:500 (WB)
VGLUT1 Guinea pig 1:2000 (IF andWB) Chemicon/AB5905 Melone et al. (2005)
VGLUT1 Rabbit 1:500 (II) Synaptic system/135303 Takamori et al. (2001)
VGLUT2 Guinea pig 1:2000 (IF andWB) Chemicon/AB5907 Cubelos et al. (2005), Liu et al. (2005)
VGLUT2 Rabbit 1:500 (II) Synaptic system/135403 Takamori et al. (2001)
SYT1 Mouse 1:1500 (IF andWB) Synaptic system/105011 Brose et al. (1992), Von Kriegstein et al. (1999)
SYT2 Rabbit 1:800 (IF) Synaptic system/105123 Johnson et al. (2010)
1:1000 (WB)
SV2A Rabbit 1:1500 (IF) Synaptic system/119002 Janz and Sudhof (1999)
1:80.000 (IF-TSA)
1:1000 (WB)
SV2B Rabbit 1:1500 (IF) Synaptic system/119102 Janz and Sudhof (1999)
1:80.000 (IF-TSA)
1:1000(WB and EM)
Rab3a Mouse 1:1500 (IF) Synaptic system/107111 Matteoli et al. (1991)
1:1000 (WB)
Rab3c Rabbit 1:1500 (IF) Synaptic system/107203 Cai et al. (2008)
1:1000 (WB)
˚GP, guinea pig; M, mouse; R, rabbit; *IF, immunoﬂuorescence; IF-TSA, immunoﬂuorescence with tyramide signal ampliﬁcation;WB, western blotting; II, immunoiso-
lation; EM, electron microscopy. Western blotting studies for VGLUT1, SYT1, SYT2, SV2A, and SV2B were performed with 5μg of protein, those for VGAT, VGLUT2,
Rab3a, and Rab3c with 10μg.
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temperature in a solution containing a mixture of the primary
antibodies (see Table 2). The next day, sections were incubated in
10% NGS (30 min) and in a mixture of the appropriate secondary
ﬂuorescent antibodies (1 h; Table 2). Sections were then mounted,
air-dried, and cover slipped using Vectashield mounting medium
(H-1000; Vector). For all experimental series (i.e., the vesicular
transporters and a presynaptic proteins), the VGLUT1, VGLUT2,
and VGAT series were run in parallel to minimize the variability
of experimental conditions.
Double-labeled sections were examined using a Leica TCS-SP2
confocal laser microscope equipped with an argon (488 nm) and a
helium/neon (543 nm) laser for excitation of FITC and TRITC,
respectively. Green and red immunoﬂuorescence were imaged
sequentially. Control experiments with single-labeled sections and
sections incubated eitherwith twoprimary antibodies andone sec-
ondary antibody,orwith one primary antibody and two secondary
antibodies revealed no appreciable FITC/TRITC bleed-through or
antibody cross-reactivity.
Images from all experimental series were from the parietal cor-
tex and were acquired from randomly selected subﬁelds in layers
II–VI (at least four to six per layer; two to four sections per ani-
mal; 14 rats). Layer I was not sampled because it hardly contains
VGAT+puncta (Chaudhry et al., 1998;Minelli et al., 2003). Images
were acquired using a ×60 oil immersion lens (numerical aper-
ture 1.4; pinhole 1.0 and image size 1024× 1024 pixels, yielding
a pixel size of 0.06μm) from a plane in which the resolution of
both stainswas optimal and never>1.8μmfrom the surface (Mel-
one et al., 2005). Signal acquisition was optimized through the “Q
LUT”button, which permitted direct visualization of pixel satura-
tion; photomultiplier gain was set so that the brightest pixels were
just slightly below saturation, and the offset such that the dark-
est pixels were just above zero. To avoid bleed-trough between
green and red ﬂuorescence, images were acquired sequentially. To
improve the signal/noise ratio, 15 frames/image were averaged.
Quantitative analysis was performed in ∼8,000 randomly
selected subﬁelds measuring about 25μm× 25μm from the
1024× 1024 pixel images. In order to minimize fusion of puncta,
contrast of each image was manually adjusted within the maxi-
mum range of levels for each color channel. Preliminary studies
(not shown) showed that gain/contrast changes within the spec-
trum used did not alter signiﬁcantly the percentage of co-localized
puncta (Bragina et al., 2010). Then, without reducing the image
resolution, each channel was examined separately to identify and
manually count immunopositive puncta; the two channels were
then merged and the number of co-localizing puncta was counted
manually. Puncta were considered double-labeled when overlap
was complete or occupied most of the immunopositive puncta
and they exhibited morphological similarity (Bragina et al., 2007,
2010; Figure 2).
SYNAPTIC VESICLES IMMUNOISOLATION STUDIES
Eupergit C1Z methacrylate microbeads (1μm in diameter; Röhm
Pharmaceuticals, Darmstadt, Germany) were either blocked with
glycine or conjugated with afﬁnity-puriﬁed goat anti-rabbit anti-
bodies (IgG; Sigma, Milan, Italy) as previously described (Burger
et al., 1991). Afﬁnity-puriﬁed anti-VGAT (R), anti-VGLUT1 (R),
or anti-VGLUT2 (R) antibodies (Table 1) were conjugated with
FIGURE 1 |VGLUT1,VGLUT2,VGAT (R, rabbit; M, mouse), SYT1, SYT2,
SV2A, SV2B, Rab3a, and Rab3c antibodies recognized bands of ∼55,
60, 57, 65, 65, 100, 95, 25, and 25kDa in the order, in crude membrane
fractions of rat cerebral cortex.
Table 2 | Dilutions of antibodies in double-labeling studies.
Primary antibodies Secondary antibodies Dilutions
VGLUT1/SYT1 FITC–GAPA/TRITC–GAMC 1:100/1:100
VGLUT1/SYT2 FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT1/SV2A FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT1/SV2B FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT1/Rab3a FITC–GAPA/TRITC–GAMC 1:100/1:100
VGLUT1/Rab3c FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT2/SYT1 FITC–GAPA/TRITC–GAMC 1:100/1:100
VGLUT2/SYT2 FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT2/SV2A FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT2/SV2B FITC–GAPA/TRITC–GARB 1:100/1:100
VGLUT2/Rab3a FITC–GAPA/TRITC–GAMC 1:100/1:100
VGLUT2/Rab3c FITC–GAPA/TRITC–GARB 1:100/1:100
VGAT/SYT1 FITC–GARD/TRITC–GAMC 1:100/1:100
VGAT/SYT2 FITC–GAME/TRITC–GARB 1:100/1:100
VGAT/SV2A FITC–GAME/TRITC–GARB 1:100/1:100
VGAT/SV2B FITC–GAME/TRITC–GARB 1:100/1:100
VGAT/Rab3a FITC–GARD/TRITC–GAMC 1:100/1:100
VGAT/Rab3c FITC–GAME/TRITC–GARB 1:100/1:100
SYT1/SYT2 FITC–GAME/TRITC–GARB 1:100/1:100
SV2A/SV2B bGAR (FITC)F/TRITC–GARB 1:200 (1:50)/1:100
SV2B/SV2A bGAR (FITC)F/TRITC–GARB 1:200 (1:50)/1:100
Rab3a/Rab3c FITC–GAME/TRITC–GARB 1:100/1:100
AFluorescein isothiocyanate-conjugated goat anti-guinea-pig IgG (FI-7000, Vec-
tor; Burlingame, CA, USA); Btetramethylrhodamine isothiocyanate-conjugated
goat anti-rabbit IgG (T-2769, Molecular Probes; Poort Gebouw, The Nether-
lands); Ctetramethylrhodamine isothiocyanate-conjugated goat anti-mouse IgG
(T-2762, Molecular Probes); Dﬂuorescein isothiocyanate-conjugated goat anti-
rabbit IgG (FI-1000, Vector); Eﬂuorescein goat anti-mouse IgG (F-2761, Molecular
probes); Fﬂuorescein-conjugated tyramide (TSA system).
the covalently bound secondary antibodies, generating IgG-coated
anti-VGAT, anti-VGLUT1, or anti-VGLUT2 beads. Beads coated
only with glycine or secondary antibodies were used as nega-
tive controls (mock beads). Aliquots of the LS1 fraction obtained
from osmotic lysis of adult rat cortical synaptosomes (150–300μg
protein/sample; Huttner et al., 1983) was incubated for 2–4 h at
4˚C in phosphate-buffered saline (PBS) with the various bead
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FIGURE 2 | Analysis of confocal microscopy images of cortical
sections.The ﬁgure shows examples from VGLUT1/SYT1 [row (A)],
VGLUT2/Rab3a [row (B)], and VGAT/SV2A series [row (C)]. To minimize
the fusion of puncta, the contrast of each image was manually adjusted
within the maximum range of levels for each color channel, which was
examined separately to identify and count manually immunopositive
puncta (ﬁrst and second columns). Following merging, puncta were
considered double-labeled when the overlap was complete or it occupied
most of the area of the puncta and they were morphologically similar
(arrowheads in fourth columns). Puncta not meeting these criteria (e.g.,
those indicated by arrows) were not considered double-labeled. Bars:
2μm.
preparations (50–70μl settled beads in 500μl ﬁnal volume) under
constant rotation. After centrifugation at 1000× g for 1 min and
repeated washes in PBS, corresponding amounts of bead pellets
and supernatant fractions were solubilized in sample buffer and
subjected to SDS-PAGE on 7 and 12% polyacrylamide gels. Gels
were electrophoretically transferred to nitrocellulose membranes
and immunoblotted with polyclonal or monoclonal SYT1/SYT2,
SV2A/SV2B, and Rab3a/Rab3c antibodies (Table 1). Speciﬁc
immunoreactivity was revealed using peroxidase-conjugated sec-
ondary antibodies and the chemiluminescence detection system,
as described (Bragina et al., 2007). Quantiﬁcation of recovered
immunoreactivity was performed by densitometric analysis of the
ﬂuorograms and by data interpolation into a standard curve of rat
brain LS1 fraction run in parallel with the unknown samples. The
amounts of synaptic proteins associated with the immunoisolated
vesicles were expressed in percent of the respective the total input
of LS1 fraction added to the samples. Experiments were repeated
at least ﬁve times.
ELECTRON MICROSCOPY
Four sections/rat (n = 2) were processed for immunoperoxidase
technique and prepared for electron microscopy as described in
previous studies (Bragina et al., 2007, 2010). After completion of
the immunoperoxidase procedure, sections were ﬂat-embedded
in Epon–Spurr (Bragina et al., 2007); then small blocks of tissue
containing layer V were selected by light microscope inspection,
glued to blank epoxy, and sectioned with an ultramicrotome. The
most superﬁcial ultrathin sections were examined with a Philips
EM 208 electron microscope (Eindhoven, The Netherlands) cou-
pled to a MegaView-II high resolution CCD camera (Soft Imaging
System; Munster, Germany). Identiﬁcation of proﬁles was based
on established morphological criteria (Peters et al., 1991).
RESULTS
The distribution of VGLUT1,VGLUT2,VGAT, SYT1, SYT2, SV2A,
SV2B, Rab3a, and Rab3c immunoreactivities was as previously
described (Moya et al., 1992; Bajjalieh et al., 1994; Ullrich et al.,
1994; Bellocchio et al., 1998; Chaudhry et al., 1998; Kaneko et al.,
2002;Minelli et al., 2003;Alonso-Nanclares et al., 2004;Conti et al.,
2005). All VGAT+ puncta (e.g., Chaudhry et al., 1998; Minelli
et al., 2003) and the vast majority of VGLUT1+ and VGLUT2+
puncta (Kaneko et al., 2002) areAT. Since someastrocytic processes
express VGLUT1 or VGLUT2 (Bezzi et al., 2004; Montana et al.,
2004) and some of the presynaptic proteins analyzed here (Mon-
tana et al., 2006), it is possible that someVGLUT1+ andVGLUT2+
puncta may include rare astrocytic processes. However, consider-
ing the paucity of VGLUTs expressed in astrocytes and the elevated
number of puncta studied in present studies, the possible bias
appears negligible.
We also preliminarily studied the degree of co-localization
between pairs of isoforms (SYT1/SYT2, SV2A/SV2B, and
Rab3a/Rab3c) in 12 sections from two animals. Co-localization
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was detected in 21.9% of SYT1+ and 33.4% of SYT2+ puncta; in
27.6% of SV2A+ and 48.6% of SV2B+ puncta; and in 34.1% of
Rab3a+ and 64.2% of Rab3c+ puncta. Since all pairs of protein
isoforms were not highly co-localized, we investigated immuno-
cytochemically whether SYT1 and 2, SV2A and B, Rab3a and c are
differentially expressed inVGLUT1+,VGLUT2+, andVGAT+AT.
EXPRESSION OF SYT1, SYT2, SV2A, SV2B, Rab3a, AND Rab3c IN
CORTICAL VGLUT1+, VGLUT2+, AND VGAT+ AXON TERMINALS AND
SYNAPTIC VESICLES
Expression of presynaptic proteins in VGLUT1+ cortical AT was
studied in 38 sections from nine rats. Results showed that 60.2% of
VGLUT1 were SYT1+, 36.7% were SYT2+, 81.7% SV2A+, 87.7%
SV2B+, 79.1% Rab3a+, and 20.2% Rab3c+ (Figure 3; Table 3
FIGURE 3 | Co-localization of SYT1, SYT2, SV2A, SV2B, Rab3a, and
Rab3c inVGLUT1+,VGLUT2+, andVGAT+ axon terminals in cerebral
cortex. Values (means±SEM) refer to the percentages of total puncta
positive for the respective protein isoform for each of the three terminal
populations identiﬁed based on the speciﬁc vesicular transporter.
for details). Analysis of VGLUT2+ cortical terminals (40 sections
from 10 animals) showed that 59.9% of them were SYT1+, 23.4%
SYT2+, 41.1% SV2A+, 46.5% SV2B+, 42% Rab3a+, and 40.7%
Rab3c+ (Figure 3; Table 3 for details). Analogous analysis of
VGAT+ terminals (44 sections from10 rats) revealed that 49.4%of
them were SYT1+, 81.8% SYT2+, 95.7% SV2A+, 16.5% SV2B+,
61.8% Rab3a+, and 61.7% Rab3c+ (Figure 3; Table 3 for details).
The degree of co-localization between vesicular transporters and
presynaptic proteins studied here did not exhibit any differential
laminar distribution.
Previous studies reported that in neocortex SV2B is preferen-
tially expressed at glutamatergic neurons (Bajjalieh et al., 1994).
The observation that SV2B was present in some VGAT+ ﬂuores-
cent terminals was therefore unexpected. To verify whether known
GABAergic cortical synapses expressed SV2B, we performed elec-
tron microscopy studies in pre-embedded immunoperoxidase
material. Our analysis was limited to AT forming symmetric
synapses on pyramidal cell bodies in layer V, which are GABAergic
and express VGAT (Ribak, 1978; Houser et al., 1984; Chaudhry
et al., 1998). Besides conﬁrming that numerous asymmetric
synapses are SV2B+, these studies showed that in some cases
AT forming perisomatic symmetric synapses were indeed SV2B+
(Figures 4A,B).
These studies provide information on whether a given pro-
tein participating in neurotransmitter release is expressed above
the threshold for immunocytochemical detection in a subpopu-
lation of identiﬁed AT; if this occurs, that terminal is considered
to express that protein. However, the percentages reported above
result from an all-or-none evaluation of the presence/absence
of a given protein in a given terminal and do not provide
Table 3 | SYT1 and 2, SV2A and B, and Rab3a and c inVGLUT1,
VGLUT2, andVGAT puncta.
VT Puncta (#) Co-localization (%) PP
VGLUT1 4640 60.2±2.4 SYT1
5087 36.7±7.5 SYT2
6707 81.7±1.0 SV2A
4750 87.7±5.5 SV2B
6351 79.1±4.0 Rab3a
3770 20.2±2.2 Rab3c
VGLUT2 2026 59.9±2.9 SYT1
3150 23.4±0.8 SYT2
3254 41.1±9.8 SV2A
2665 46.5±5.8 SV2B
3345 42.0±1.9 Rab3a
1914 40.7±3.5 Rab3c
VGAT 1558 49.4±2.0 SYT1
1758 81.8±4.6 SYT2
1106 95.7±2.8 SV2A
1793 16.5±3.8 SV2B
1855 61.8±1.4 Rab3a
849 61.7±5.4 Rab3c
VT, vesicular transporter; PP, presynaptic protein.
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FIGURE 4 | Pre-embedding electron microscopy studies show that SV2B immunoreactivity [arrows in (A,B)] is present in axon terminals forming both
asymmetric [arrowheads in (A); layerV] and symmetric [arrowheads in (B); layerV] synaptic contacts. AxT, axon terminal; Den, dendrite; N, pyramidal
neuron. Scale bar: 500 nm (A,B).
any information on the expression levels of this protein in
glutamatergic and GABAergic SVs. We therefore set up a study to
investigate the complement of SYT1, SYT2, SV2A, SV2B, Rab3a,
and Rab3c in immunoisolated VGLUT1, VGLUT2, and VGAT
SV populations from the rat neocortex. Immunoisolation studies
showed that the expression levels of the protein isoforms varied in
the three populations of SVs.
Expression levels of SYT1 was highest in VGLUT1–SVs
(26.7± 4.3% of total immunoreactivity), while its levels were
lower in VGLUT2–SV (12.9± 4.3%) and VGAT SVs (7.6± 1.9%),
while SYT2 expression was similar in the three SV groups
(27.3± 3.8, 30.2± 4.2, and 23.0± 2.3% for VGLUT1, VGLUT2,
and VGAT SV populations, respectively). Expression levels of
SV2A was similarly high in all three SV populations (38.4± 2.4,
34.8± 4, and 22.6± 1.1% for VGLUT1, VGLUT2, and VGAT SVs,
respectively), while SV2B levels were similar to those of SV2
in glutamatergic SVs (45.5± 3.1 and 28.9± 6.3% in VGLUT1
and VGLUT2 SVs, respectively), but very low in VGAT SVs
(0.8± 0.43%). Finally, Rab3a levels were similar in the three
SV groups (4.7± 1.1, 3.5± 0.7, and 3.1± 2.1% for VGLUT1,
VGLUT2, and VGAT SVs, respectively), while Rab3c levels
were higher in VGLUT1–SVs (11.9± 1.4%) than in VGLUT2
(6.8± 1.0%) or VGAT (3.7± 2.3%) SVs (Figure 5).
DISCUSSION
The quantitative studies reported here showed that SYT1/2,
SV2A/B, and Rab3a/c are differentially expressed in glutamater-
gic and GABAergic terminals, and that in VGLUT1,VGLUT2, and
VGAT terminals the levels of these proteins associated with were
also variable.
Under our experimental conditions, SYT1 distribution was
similar at glutamatergic and GABAergic terminals, whereas SYT2
expression was more robust in GABAergic terminals. The lat-
ter ﬁnding extend quantitatively the results of previous studies
showing an association between SYT2 and GABAergic neurons
(Pang et al., 2006a; Fox and Sanes, 2007). As synapses expressing
SYT2 display a faster transmitter release than those expressing
SYT1 (Xu et al., 2007), it is conceivable that expression of a
given SYT isoform contributes to speciﬁc release properties. As
far as SV2A and B distribution in the three classes of terminals
is concerned, Bajjalieh et al. (1994) and Gronborg et al. (2010)
showed that SV2B is preferentially localized to glutamatergic
FIGURE 5 | Expression of SYT1, SYT2, SV2A, SV2B, and Rab3a and c in
VGLUT1+,VGLUT2+, andVGAT+ SVs. (A) Glutamatergic and GABAergic
SVs were immunoisolated from the LS1 fraction of rat cerebral cortex using
beads coupled with either rabbit VGLUT1, VGLUT2, or VGAT antibodies.
After immunoisolation, corresponding amounts of pellet and supernatant
(SUP) fractions were subjected to immunoblotting with anti-SYT1 and -SYT2
antibodies, anti-SV2A/SV2B antibodies, or anti-Rab3a/Rab3c antibodies. (B)
Quantiﬁcation of the recovered immunoreactivities was carried out by
densitometric scanning and interpolation of the data into a standard curve
of rat brain LS1 fraction, and expressed as percent of the total input of LS1
added to the samples. The percentage of SYT1/SYT2, SV2A/SV2B, and
Rab3a/Rab3c immunoreactivities (IR) detected in SVs immunoisolated with
anti-VGLUT1 (VGLUT1–SV; upper left/right panel), anti-VGLUT2 (VGLUT2–SV;
lower left/right panel), or anti-VGAT (VGAT SV; upper right/right panel) beads
are shown as means (±SEM) of ﬁve independent experiments.
neurons. Our light and electron microscopic immunocytochem-
ical studies add the observation that some VGAT+ terminals
express SV2B. However, immunoisolation studies showed very
low levels of SV2B in VGAT+ vesicles. The most likely explana-
tion for this discrepancy is presumably correlated to the paucity
of SV2B expression in GABAergic terminals. Finally, in our hands
Rab3a distribution was more widespread than that of Rab3c in
VGLUT1+ terminals, whereas it was similar in VGLUT2 and
VGAT+ terminals.
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Besides distribution frequency in the nerve terminal popula-
tions, the SV protein isoforms displayed also remarkably different
expression levels in VGLUT1, VGLUT2, and VGAT immunoiso-
lated SVs, with SYT2 levels higher than SYT1 levels in VGLUT2
and VGAT SVs and SV2B levels very low compared to SV2A levels
in VGAT SVs.
In our previous studies on the heterogeneity of glutamatergic
and GABAergic release machinery in neocortex, we demonstrated
quantitatively remarkable differences in the expression of presy-
naptic proteins participating in transmitter release between gluta-
matergic and GABAergic AT and between VGLUT1 and VGLUT2
glutamatergic terminals, with SYNI, SYNII, SYPI, SNAP-25, and
STX1A highly expressed in VGLUT1+ AT, SNAP-23 highly
expressed in VGLUT2+ AT and STX1B and VAMP1 more
expressed in VGAT+ AT (Bragina et al., 2007, 2010). The present
observation that other presynaptic proteins involved in transmitter
release exhibit differences between glutamatergic and GABAergic
AT, with SV2B preferentially expressed in VGLUT1+ terminals,
and SYT2 and Rab3c in VGAT+ ones, strengthens the notion
that glutamatergic and GABAergic exocytotic machineries greatly
differ in their complement of presynaptic proteins.
Comparison between double-labeling studies, which yields an
all-or-none evaluation of expression of a given presynaptic protein
in AT, and SV immunoisolation studies, which provide quantita-
tive information on protein expression in homogeneous popula-
tions of SVs, allows the deﬁnition of amore complete picture of the
differential expression of key actors of exocytosis and adds to the
issue of molecular heterogeneity of glutamatergic and GABAergic
terminals. For example, the VGLUT1 series indicate that in about
50% of VGLUT1+ terminals ∼40% of SVs expressed SYT1 and
∼70% expressed SYT2 (Figure 6), that in most of them about
50% of SVs expressed SV2A and B, and that in the majority of
VGLUT1+ terminals few SVs expressed Rab3a while most of them
expressed Rab3c. Thus, the data support the concept that mole-
cular heterogeneity within glutamatergic terminals and between
these terminals and GABAergic ones is achieved not only by the
presence/absence of a given protein, but also by the relative abun-
dance of SVs expressing a given protein and the number of copies
of the protein sorted to each SV (see also Micheva et al., 2010).
In present and previous studies (Bragina et al., 2007, 2010),
we reported on the heterogeneous expression of SNARE, calcium
sensor, and regulatory proteins atVGLUT1,VGLUT2, andVGAT+
cortical AT. Glutamate- and GABA-operated synapses exhibit dif-
ferent forms of frequency-dependent short-term synaptic plastic-
ity (Galarreta and Hestrin, 1998; Varela et al., 1999; Thomson,
FIGURE 6 | Hypothetical distribution of SYT1/2 inVGLUT1+ and
VGLUT2+ glutamatergic andVGAT+ GABAergic cortical terminals.
Based on a correlative analysis of confocal and immunoisolation data, the
scenario proposed is highly schematic (e.g., the total amount of a SV-related
protein is equally distributed among all positive terminals), and does not
take into account the number of proteins/vesicles, but it emphasizes the
concept that the amount of a SV-related protein is variable in positive
terminals. Shaded terminals indicate terminals expressing a given protein;
black circles indicate levels of expression of the protein in immunoisolated
SVs. Four terminals make up 100%; similarly, 10 vesicles makes up 100%.
2000), and there is evidence that different isoforms of presynaptic
proteins regulate SVs availability at glutamate and GABA synapses
(Moulder et al., 2007). Functional differences exist also between
VGLUT1 andVGLUT2 terminals: the ﬁrst ones appear to be associ-
ated with low release probability synapses, whereas the latter ones
participate in synapses exhibiting higher release probability (Gil
et al., 1999; Fremeau et al., 2001). Notwithstanding the known role
of other proteins in determining release efﬁciency (Weston et al.,
2011), the present results support the notion that heterogeneous
expression levels of presynaptic proteins may contribute to differ-
ences in release probability and plasticity (Staple et al., 1997, 2000).
Our observation that two types of glutamatergic and GABAergic
AT expressed different patterns of presynaptic proteins are in line
with this scenario and may contribute to explain functional dif-
ferences. Whether the different patterns of presynaptic protein
expression in the two types of glutamatergic and in GABAergic
AT are stable throughout the animal’s life or are regulated during
development and/or aging will prove a challenge of great interest
for future studies.
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